Litcius/Paper detail

Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy

Xiujuan Liu, Xu-Liu, Xiaojing Pang, Xin -Ying Yuan, Guang-Xi Yu, Yin-Ru Li, Yong-Feng Guan, Yanbing Zhang, Jian Song, Qiurong Zhang, Sai‐Yang Zhang

2021Bioorganic & Medicinal Chemistry41 citationsDOIOpen Access PDF

Topics & Concepts

Bruton's tyrosine kinaseIbrutinibTyrosine kinaseCancer researchTargeted therapyC-MetSignal transductionChemistryKinaseCancerChronic lymphocytic leukemiaImmunologyBiologyReceptorLeukemiaBiochemistryGeneticsHepatocyte growth factorChronic Lymphocytic Leukemia ResearchProtein Degradation and InhibitorsMultiple Myeloma Research and Treatments
Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy | Litcius